Farxiga achieved a positive result in the Phase III DECLARE-TIMI 58 trial, a large cardiovascular outcomes trial in 17,000 patients with type-2 diabetes
AstraZeneca today announced positive results...
Read MoreAstraZeneca today announced positive results...
Read MoreRoche announced today the global...
Read MoreBiocon Ltd. today announced that...
Read MoreIQVIA is expanding its strategic collaboration...
Read MoreIndian innovations marked galore at...
Read MoreCipla Limited announced that it...
Read MoreThe Delhi High Court has...
Read MoreThe European multicentre, two-parallel, non-randomised...
Read MoreMylan, a global pharmaceutical company...
Read More